Preclinical
Artificial Intelligence
Not One Size Suits All Drug Hunters Proceed to Pursue the Ultimate Breakthrough Are We Aiming for Faster? Cheaper? Higher? Exploring ML Approaches in Preclinical Drug Discovery Seamless...
ML Models Must Match Their Use Cases in Drug DiscoveryCo-authored by LabGenius’ CTO, Leo Wossnig.Drug discovery is historically slow, expensive, and riddled with failures — AI/ML is changing this paradigm.The drug development process stays...
Recent posts
